-
1.
公开(公告)号:US20230134821A1
公开(公告)日:2023-05-04
申请号:US17966227
申请日:2022-10-14
发明人: ARTEM TCHERKASSOV , PAUL S. RENNIE , FUQIANG BAN , ERIC J.J. LEBLANC , LAVINIA A. CARABET , NADA LALLOUS , KRITI SINGH , HELENE MORIN , ANH-TIEN TON
IPC分类号: C07C237/22 , C07C255/66 , C07C275/30 , C07C311/18 , C07C335/16 , C07C335/18 , C07D211/42 , C07D213/40 , C07D213/61 , C07D231/14 , C07D239/42 , C07D241/24 , C07D249/08 , C07D261/08 , C07D265/30 , C07D265/36 , C07D277/36 , C07D307/14 , C07D311/16 , C07D333/20 , C07D403/06 , C07D403/12 , C07D405/12 , C07D409/06 , C07D413/12 , C07D417/06 , C07D417/12 , C07D471/04
摘要: Provided herein are Myc-Max inhibitory compounds having the structure of Formula (I) and compositions thereof for use in the treatment of cancer. In particular, the Myc-Max inhibitory compounds may be useful for the treatment of cancers selected from one or more of: prostate cancer, breast cancer, colon cancer, cervical cancer, small-cell lung carcinomas, neuroblastomas, osteosarcomas, glioblastomas, melanoma and myeloid leukaemia.
-
公开(公告)号:US11639348B2
公开(公告)日:2023-05-02
申请号:US16257920
申请日:2019-01-25
发明人: Stephen G. Withers , Zhizeng Gao
IPC分类号: G01N33/68 , C07D407/12 , G01N33/573 , G01N33/58 , C12Q1/34 , C12Q1/04
摘要: Provided herein are compounds having the structure of Formulas A-D and compositions thereof for use in the detection and quantification of viral neuraminidase. In particular, the compounds may be useful for the evaluation of viral strains and for vaccine evaluation.
-
公开(公告)号:US20230132202A1
公开(公告)日:2023-04-27
申请号:US17793907
申请日:2021-02-19
IPC分类号: C09D133/26 , C09D5/16 , C08L33/26 , C08K3/28 , C09D5/14
摘要: Provided herein are compositions including polymeric binder or a salt thereof, high molecular weight polymer, pharmaceutically active agent and a low molecular weight cross-linking agent, methods for using the compositions to coat a substrate, and methods for making the compositions. Alternatively, the composition may include a polymeric binder or a salt thereof, high molecular weight polymer and a pharmaceutically active agent. In particular, the substrate may form part of an apparatus on which it would be beneficial to limit biofouling and/or protein binding.
-
公开(公告)号:US11608353B2
公开(公告)日:2023-03-21
申请号:US16675535
申请日:2019-11-06
IPC分类号: A61K31/7034 , A61K31/7048 , A61K31/7032 , C07H15/26 , C07C33/26 , C07D311/30 , C07H15/203 , A23G4/12 , A23L33/105 , C07H1/06
摘要: There are provided compounds of Formula I: various compositions thereof and methods for their use in the inhibition of α-amylase.
-
公开(公告)号:US11584663B2
公开(公告)日:2023-02-21
申请号:US16851327
申请日:2020-04-17
发明人: Fariborz Taghipour
IPC分类号: C02F1/32 , C02F1/72 , C02F103/02
摘要: A reactor that operates with ultraviolet light emitting diodes (UV-LEDs) to attain UV photoreactions or UV photo-initiated reaction in a fluid flow for various applications, including water purification. The UV-LED reactor is comprised of a conduit means for passing fluid flow, an ultraviolet light emitting diode (UV-LED), and a radiation-focusing element to focus the UV-LED radiation to the fluid in the longitudinal direction of the conduit. The UV-LED reactor may include photocatalysts or chemical oxidants, which are activated by UV emitted by UV-LEDs for photocatalytic and photo-initiated reactions.
-
6.
公开(公告)号:US20230051538A1
公开(公告)日:2023-02-16
申请号:US17283292
申请日:2019-10-07
摘要: The disclosure pertains to conformational epitopes in alpha-synuclein, antibodies thereto and methods of making and using immunogens and antibodies specific thereto. In particular antibodies raised to cyclic compounds comprising at least 3 amino acids of EKTKEQ (SEQ ID NO: 1) selectively recognize misfolded oligomeric alpha-synuclein and are able to inhibit alpha-synuclein propagation and toxicity.
-
公开(公告)号:US11566643B2
公开(公告)日:2023-01-31
申请号:US16650109
申请日:2018-09-25
发明人: Fariborz Taghipour
摘要: A fluid flow conduit according to one embodiment comprises: a body comprising a channel-defining surface which defines a principal flow channel extending in a longitudinal direction, wherein the body defines an interior flow region comprising the principal flow channel; an inlet for introducing fluid into the interior flow region, the inlet shaped so that an average velocity of fluid entering the interior flow region from the inlet is oriented in an inlet flow direction non-parallel to the longitudinal direction; and an outlet for conveying fluid out of the principal flow channel, the outlet spaced apart from the inlet in the longitudinal direction such that fluid that passes from the inlet to the outlet passes through at least a portion of the principal flow channel; wherein the fluid flow conduit defines a recess in the interior flow region and facing the inlet.
-
公开(公告)号:US20230010064A1
公开(公告)日:2023-01-12
申请号:US17779525
申请日:2020-09-17
发明人: Mirza Sarwar , Sylvester Zhang , John Madden
IPC分类号: H05K1/02 , H05K3/00 , H05K1/03 , H05K3/18 , H05K1/09 , H05K3/46 , C09D11/033 , C09D1/00 , C23C18/38 , C23C18/16 , C23C28/02 , C25D5/56 , C25D3/38
摘要: A method for fabricating a circuit board comprises preparing an elastomeric substrate having a roughened surface. The elastomeric substrate is stretched before an electrically conductive material is electrolessly deposited onto the roughened surface. A suitable amount of electrically conductive material is deposited onto the elastomeric substrate before the elastomeric substrate is released from its stretch.
-
公开(公告)号:US11529148B2
公开(公告)日:2022-12-20
申请号:US15952093
申请日:2018-04-12
发明人: Robert Meek , Qingan Zhu , Timothy Schwab , Robin John Noel Coope , Jared Slobodan , Scott Young
摘要: Devices for treating a bone and methods of inserting such devices into a bone are disclosed. A device for treating a bone may include a flexible tube, a stiffening mechanism and an actuator. The flexible tube has a distal end and a proximal end. The stiffening mechanism within the flexible tube is configured to cause the flexible tube to become rigid. The actuator is configured to cause the stiffening mechanism to cause the flexible tube to become rigid in response to the actuator being actuated.
-
10.
公开(公告)号:US20220380785A1
公开(公告)日:2022-12-01
申请号:US17773543
申请日:2020-11-01
摘要: Provided herein are enzymatic compositions for protein O-glycosylation and sialylation, methods and systems associated therewith. In particular, the composition for in vivo sialylation of therapeutic proteins. The composition comprises a polypeptide N-acetylgalactosaminyltransferase; a β-1,3-galactosyltransferase; an UDP-Glc/GlcNAc 4-epimerase; a disulfide bond isomerase; and an α-2,3-sialyltransferase or an α-2,6-sialyltransferase. Furthermore, provided herein are compositions for efficient and complete O-glycosylation and di-sialylation of therapeutic proteins.
-
-
-
-
-
-
-
-
-